Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gilad Altshuler Holdings is a private Israeli investment holding company that serves as the personal investment vehicle for Gilad Altshuler, the co-founder and co-CEO of Altshuler Shaham Investment House. The company is a significant shareholder in the Altshuler Shaham Group, which is one of Israel's largest institutional investors, managing a diverse portfolio of pension funds, provident funds, and mutual funds. While the holding company itself does not directly develop therapeutics, it plays a crucial role in the life sciences ecosystem as a major source of capital for biotech and healthcare companies through its institutional investment arms. Its influence extends across the Israeli financial landscape, providing strategic funding and market stability to various sectors, including high-tech and healthcare. The firm is headquartered in Tel Aviv and operates as a central entity within the Altshuler Shaham Group's corporate structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gilad Altshuler Holdings.